A diabetes patient’s ambivalence about changing their diet or taking their insulin can stand between successful management of their disease and a further escalation that could lead to blindness, limb removal, or even death.
That’s where motivational interviewing makes a difference, says Maureen Hennessey, PhD, senior vice president and director of quality and population health solutions, and Elizabeth Oyekan, PharmD, senior director of quality and population health solutions, at New York-based Precision for Value. The company consults with pharmaceutical and life science clients in demonstrating the value and outcomes of their medical products.
Hennessey and Oyekan discussed how motivational interviewing can improve patient outcomes at the Academy of Managed Care Pharmacy Managed Care and Specialty Pharmacy Annual Meeting, which took place in Boston April 23 to 26.
Hennessey describes motivational interviewing as a patient-centric style of communication that helps to elicit and motivate change. Motivational interviewing strategies are more collaborative than coercive or combative and more supportive than directive, she adds.
If, for example, a patient with diabetes typically eats potatoes for dinner every night, that can interfere with their diabetes treatment plan. Rather than arguing with a patient and telling them they shouldn’t eat potatoes, motivational interviewing techniques can help determine their willingness to eat a smaller portion size or eat potatoes less often, says Hennessey.
She says there are four steps of motivational interviewing, which include:
Oyekan says compassion and empathy are key to the practice of motivational interviewing.
Exercising both is helpful when determining why a patient isn’t adhering to treatment recommendations, such as failing to take their medications, says Hennessey.
Asking a patient to tell you more about why they’re not taking their medications is helpful, says Hennessey.
She shared the example of a male patient with diabetes who didn’t take his medications. With this patient, his father had a negative outcome as a result of his diabetes medications. The patient then learned that there were new, more effective medications available.
Healthcare professionals first need to understand where the patient is coming from, and then they need to ask for permission to educate them about new treatments, says Hennessey, noting that asking for permission to provide that information is key. It also gives the patient a collaborative stance from which to get more engaged in their own treatment plan.
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
July 14th 2025Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic kidney disease (CKD) associated with type 2 diabetes. This new approval extends its use to a broader patient population.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen